<code id='DEFB35C50B'></code><style id='DEFB35C50B'></style>
    • <acronym id='DEFB35C50B'></acronym>
      <center id='DEFB35C50B'><center id='DEFB35C50B'><tfoot id='DEFB35C50B'></tfoot></center><abbr id='DEFB35C50B'><dir id='DEFB35C50B'><tfoot id='DEFB35C50B'></tfoot><noframes id='DEFB35C50B'>

    • <optgroup id='DEFB35C50B'><strike id='DEFB35C50B'><sup id='DEFB35C50B'></sup></strike><code id='DEFB35C50B'></code></optgroup>
        1. <b id='DEFB35C50B'><label id='DEFB35C50B'><select id='DEFB35C50B'><dt id='DEFB35C50B'><span id='DEFB35C50B'></span></dt></select></label></b><u id='DEFB35C50B'></u>
          <i id='DEFB35C50B'><strike id='DEFB35C50B'><tt id='DEFB35C50B'><pre id='DEFB35C50B'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:21
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          As JPM 2024 winds down, some health tech firms project optimism
          As JPM 2024 winds down, some health tech firms project optimism

          AdobeYou’rereadingthewebeditionofSTAT’sHealthTechnewsletter,ourguidetohowtechnologyistransformingthe

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

          FogPharmaCEOMathaiMammenVenrockSANFRANCISCO—SixmonthsintohistenureasCEOofcancerstartupFogPharma,Math